|
|
|
|
|
|
Found 45 studies with search of: | "Pimecrolimus" |
Hide studies that are not seeking new volunteers.
|
|
1 | Completed | Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Pimecrolimus | |||||
2 | Completed | Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis | ||||
Condition: | Dermatitis, Atopic | |||||
Interventions: | Drug: Pimecrolimus plus topical corticosteroid (TCS); Drug: Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS) | |||||
3 | Completed | Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome | ||||
Condition: | Netherton Syndrome | |||||
Intervention: | Drug: Elidel (Pimecrolimus) 1% Cream | |||||
4 | Completed | Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus | |||||
5 | Completed | Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
6 | Completed | Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis | ||||
Condition: | Perioral Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
7 | Completed | Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
8 | Recruiting | 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus | |||||
9 | Active, not recruiting | Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Topical corticosteroids | |||||
10 | Completed | Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
11 | Completed | Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus | |||||
12 | Completed | Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-Moderate AD, in Patients 2- to 11- Year-Old | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus | |||||
13 | Active, not recruiting | A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems | ||||
Condition: | Coronary Disease | |||||
Interventions: | Device: Corio™ Pimecrolimus-eluting stent; Device: SymBio™ Pimecrolimus/Paclitaxel-eluting stent | |||||
14 | Completed | A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis | ||||
Condition: | Dermatitis, Atopic | |||||
Interventions: | Drug: tacrolimus ointment; Drug: pimecrolimus cream | |||||
15 | Completed | Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus Cream 1% | |||||
16 | Completed | Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus | ||||
Condition: | Discoid Lupus Erythematosus | |||||
Interventions: | Drug: Pimecrolimus 1% cream; Drug: betamethasone valerate 0.1% cream | |||||
17 | Recruiting | Cutaneous Lupus Erythematosus and Elidel | ||||
Conditions: | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid | |||||
Intervention: | Drug: Elidel (pimecrolimus) | |||||
18 | Completed | Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis | ||||
Condition: | Chronic Hand Dermatitis | |||||
Intervention: | Drug: Pimecrolimus Cream 1% | |||||
19 | Recruiting | Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-Propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound | ||||
Condition: | Healthy | |||||
Interventions: | Drug: pimecrolimus 1% cream; Drug: hydrocortisonacetat 1% cream; Drug: betamethasonvalerat 0,1% cream; Drug: clobetasol-17-propionat 0,05% cream; Drug: Placebo | |||||
20 | Completed | Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
21 | Completed | Reconstitution With Pimecrolimus Cream 1% of Steroid-Damaged Skin in Adults With Atopic Dermatitis. | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus | |||||
22 | Completed | A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis | ||||
Condition: | Atopic Eczema | |||||
Intervention: | Drug: Pimecrolimus cream 1% | |||||
23 | Completed | Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis | ||||
Condition: | Dermatitis, Atopic | |||||
Interventions: | Drug: tacrolimus ointment; Drug: pimecrolimus cream | |||||
24 | Completed | Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis | ||||
Condition: | Dermatitis, Atopic | |||||
Interventions: | Drug: tacrolimus ointment; Drug: pimecrolimus cream | |||||
25 | Active, not recruiting | Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Corticosteroid | |||||
26 | Recruiting | Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: pimecrolimus 1% cream; Drug: hydrocortison 1% cream | |||||
27 | Completed | Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Elidel(R) (pimecrolimus 1%); Device: EpiCeram(R) -ceramide based barrier repair cream | |||||
28 | Terminated | Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream | ||||
Condition: | Oral Erosive Lichen Planus | |||||
Intervention: | Drug: 1% pimecrolimus cream | |||||
29 | Completed | Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca | ||||
Condition: | Keratoconjunctivitis Sicca | |||||
Intervention: | Drug: Pimecrolimus | |||||
30 | Recruiting | Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-Atopic Pruritic Disease | ||||
Condition: | Prurigo Nodularis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Hydrocortisone | |||||
31 | Recruiting | Pimecrolimus Cream for Oral Lichen Planus | ||||
Condition: | Oral Lichen Planus | |||||
Intervention: | Drug: Pimecrolimus cream | |||||
32 | Completed | Quality of Life Study in Adults With Facial Eczema | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Placebo | |||||
33 | Recruiting | Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus | ||||
Condition: | Lichen Sclerosus | |||||
Intervention: | Drug: pimecrolimus and clobetasol | |||||
34 | Not yet recruiting | Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID) | ||||
Condition: | Coronary Disease | |||||
Intervention: | Device: Corio™ Pimecrolimus-eluting stent | |||||
35 | Completed | Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Pimecrolimus Cream 1% | |||||
36 | Completed | Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris | ||||
Condition: | Vitiligo Vulgaris | |||||
Intervention: | Drug: Application of pimecrolimus | |||||
37 | Completed | Efficacy of Elidel Cream on Erosive Oral Lichen Planus | ||||
Condition: | Lichen Planus, Oral | |||||
Intervention: | Drug: Pimecrolimus | |||||
38 | Completed | Elidel-Study: Elidel in Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Elidel-Creme | |||||
39 | Recruiting | A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis | ||||
Condition: | Seborrheic Dermatitis | |||||
Intervention: | Drug: Elidel | |||||
40 | Completed | Combination Therapy for Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | Drug: Combination of pimecrolimus and fluticasone | |||||
41 | Recruiting | A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis | ||||
Condition: | Mild to Moderate Atopic Dermatitis | |||||
Interventions: | Device: Zarzenda; Drug: Elidel | |||||
42 | Completed | Standardized Time- and Score-Oriented Treatment of Moderate and Severe Atopic Dermatitis | ||||
Condition: | Moderate to Severe Atopic Dermatitis | |||||
Interventions: | Drug: Pimecrolimus; Drug: Tacrolimus; Drug: Prednisolone; Drug: Ciclosporin A; Drug: Dermatop | |||||
43 | Completed | Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | ||||||
44 | Completed | Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis | ||||
Condition: | Psoriasis | |||||
Intervention: | ||||||
45 | Not yet recruiting | Effects of Pimecrolimus on Skin Biopsy Ex-Plants From Patients With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Intervention: | ||||||